Low-Dose Antibiotic Prophylaxis Induces Rapid Modifications of the Gut Microbiota in Infants With Vesicoureteral

William Morello1, Federica D'Amico2, Jessica Serafinelli1

  • 1Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Insights

Continuous low-dose antibiotic prophylaxis (CAP) in infants with VUR alters the gut microbiota, increasing opportunistic pathogens. This early antibiotic exposure may pose long-term health risks.

Area of Science:

  • Microbiology
  • Pediatrics
  • Gastroenterology

Background:

  • Infant gut microbiota (GM) development is crucial and influenced by environmental factors.
  • Continuous low-dose antibiotic prophylaxis (CAP) is standard for VUR to prevent urinary tract infections.
  • Understanding CAP's short-term impact on infant GM is essential.

Purpose of the Study:

  • To evaluate the short-term effects of CAP on the gut microbiota composition in infants with VUR.
  • To compare GM structure between infants exposed and not exposed to CAP.

Main Methods:

  • Analysis of gut microbiota in 87 infants (1-5 months) with VUR using 16S rRNA gene sequencing.
  • Comparison of GM profiles between infants on CAP and those not exposed.
  • Assessment of fecal short- and branched-chain fatty acids.

Main Results:

  • CAP-exposed infants showed altered GM composition, with increased Enterobacteriaceae and Bacteroidetes (e.g., Bacteroides, Parabacteroides).
  • A trend towards increased Klebsiella, associated with antibiotic resistance, was observed in CAP-exposed infants.
  • Non-CAP infants had a GM enriched in Bifidobacterium.

Conclusions:

  • Even short-term CAP significantly alters infant gut microbiota in VUR patients.
  • CAP exposure increases opportunistic pathogens and decreases beneficial bacteria.
  • Early low-dose antibiotic use may carry potential long-term clinical risks.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
45
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
263
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
417
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
671
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
85